Re: Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-resistant Prostate Cancer Cell Lines

被引：6
|
作者：
Luo, Jun [1 ]
Pienta, Kenneth J. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21287 USA
来源：
EUROPEAN UROLOGY | 2013年 / 64卷 / 02期
关键词：
D O I：
10.1016/j.eururo.2013.05.012
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339 / 340
页数：3
相关论文
共 50 条
  • [1] Re: Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-resistant Prostate Cancer Cell Lines
    Schrader, Andres J.
    Schrader, Mark G.
    Cronauer, Marcus V.
    EUROPEAN UROLOGY, 2013, 64 (01) : 169 - 170
  • [2] Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
    Li, Yingming
    Chan, Siu Chiu
    Brand, Lucas J.
    Hwang, Tae Hyun
    Silverstein, Kevin A. T.
    Dehm, Scott M.
    CANCER RESEARCH, 2013, 73 (02) : 483 - 489
  • [3] Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer
    Maughan, Benjamin L.
    Antonarakis, Emmanuel S.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (12) : 1 - 14
  • [4] Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer
    Benjamin L. Maughan
    Emmanuel S. Antonarakis
    Current Treatment Options in Oncology, 2015, 16
  • [5] The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer
    Sprenger, Cynthia C. T.
    Plymate, Stephen R.
    HORMONES & CANCER, 2014, 5 (04): : 207 - 217
  • [6] The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer
    Cynthia C. T. Sprenger
    Stephen R. Plymate
    Hormones and Cancer, 2014, 5 : 207 - 217
  • [7] Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
    Liu, Chengfei
    Lou, Wei
    Zhu, Yezi
    Nadiminty, Nagalakshmi
    Schwartz, Chad T.
    Evans, Christopher P.
    Gao, Allen C.
    CLINICAL CANCER RESEARCH, 2014, 20 (12) : 3198 - 3210
  • [8] Androgen receptor splice variant-7 predicts resistance to enzalutamide in patients with castration-resistant prostate cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Fedor, Helen L.
    Lotan, Tamara L.
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Androgen receptor independent acquired mechanisms of resistance to enzalutamide in castration-resistant prostate cancer.
    Szmulewitz, Russell Zelig
    Kregel, Steve
    Isikbay, Masis
    Cai, Yi
    Chen, James Lin
    Vander Griend, Donald J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [10] Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
    Sternberg, Cora N.
    FUTURE ONCOLOGY, 2019, 15 (13) : 1437 - 1457
12345